Literature DB >> 18544595

Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.

Sébastien Van de Velde1, Hoang Anh Nguyen, Françoise Van Bambeke, Paul M Tulkens, Jean Grellet, Véronique Dubois, Claudine Quentin, Marie-Claude Saux.   

Abstract

BACKGROUND AND AIMS: Listeria monocytogenes and Staphylococcus aureus invade and multiply in THP-1 monocytes. Fluoroquinolones accumulate in these cells, but are less active against intracellular than extracellular forms of L. monocytogenes and S. aureus. We examined whether differentiation of THP-1 monocytes into adherent, macrophage-like cells increases fluoroquinolone uptake and activity.
METHODS: THP-1 monocytes were differentiated with phorbol myristate acetate (PMA) and compared with unstimulated cells for: (i) moxifloxacin and levofloxacin accumulation; and (ii) activity against phagocytosed L. monocytogenes and S. aureus (5 h contact).
RESULTS: The differentiation of THP-1 monocytes caused: (i) a 3- to 4-fold increase in moxifloxacin uptake and a significant increase in its activity against intracellular L. monocytogenes (from 1.3 log(10) to 2.1 log(10) cfu decrease compared with the post-phagocytosis inoculum), but not against S. aureus (1.0-1.2 log(10) cfu decrease throughout); and (ii) no change in levofloxacin accumulation and intracellular activity against either L. monocytogenes or S. aureus.
CONCLUSIONS: Although differentiation of monocytes enhances the uptake and activity of moxifloxacin against L. monocytogenes, this cannot be extended to other intracellular bacteria and to levofloxacin. These results further demonstrate that antibiotic intracellular accumulation and activity are not necessarily linked and suggest that intracellular drug and pathogen combinations must be studied individually.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544595     DOI: 10.1093/jac/dkn232

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

Review 1.  The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.

Authors:  Véronique Dartois
Journal:  Nat Rev Microbiol       Date:  2014-02-03       Impact factor: 60.633

2.  Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells.

Authors:  Frédéric Peyrusson; Adam O Whelan; Margaret G Hartley; Isobel H Norville; Sarah V Harding; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2021-09-20       Impact factor: 5.191

3.  Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.

Authors:  Hoang Anh Nguyen; Olivier Denis; Anne Vergison; Anne Theunis; Paul M Tulkens; Marc J Struelens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

Review 4.  Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses.

Authors:  Anne Lenaerts; Clifton E Barry; Véronique Dartois
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

5.  Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy.

Authors:  Lloyd Tanner; Gabriel T Mashabela; Charles C Omollo; Timothy J de Wet; Christopher J Parkinson; Digby F Warner; Richard K Haynes; Lubbe Wiesner
Journal:  Microbiol Spectr       Date:  2021-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.